Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29−0.44 (-6.54%)
Close on Nov 16, 2026Market cap $283.18MP/E –Yield –
Agenus gross margin
Gross margin is gross profit as a percentage of revenue.
Agenus's gross margin for the twelve months ending Jun 30, 2026 was 99.5%. For fiscal 2025 it was 99.1%, against 99.5% the year before. The highest annual figure on record is 100.0% in fiscal 2009.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 99.1% | −0.4 |
| FY2024 | Dec 31, 2024 | 99.5% | +1.5 |
| FY2023 | Dec 31, 2023 | 98.0% | +8.8 |
| FY2022 | Dec 31, 2022 | 89.2% | −9.6 |
| FY2021 | Dec 31, 2021 | 98.8% | +1.5 |
| FY2020 | Dec 31, 2020 | 97.3% | −2.7 |
| FY2014 | Dec 31, 2014 | 100.0% | +17.6 |
| FY2013 | Dec 31, 2013 | 82.4% | −13.4 |
| FY2012 | Dec 31, 2012 | 95.8% | −4.2 |
| FY2011 | Dec 31, 2011 | 100.0% | +3.7 |
| FY2010 | Dec 31, 2010 | 96.3% | −3.7 |
| FY2009 | Dec 31, 2009 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 100.0% | +0.9 |
| Q1 FY2026 | Mar 31, 2026 | 100.0% | +0.6 |
| Q4 FY2025 | Dec 31, 2025 | 100.0% | +0.4 |
| Q3 FY2025 | Sep 30, 2025 | 97.9% | −1.5 |
| Q2 FY2025 | Jun 30, 2025 | 99.1% | −0.5 |
| Q1 FY2025 | Mar 31, 2025 | 99.4% | −0.2 |
| Q4 FY2024 | Dec 31, 2024 | 99.6% | −0.1 |
| Q3 FY2024 | Sep 30, 2024 | 99.4% | +0.7 |
| Q2 FY2024 | Jun 30, 2024 | 99.5% | +0.5 |
| Q1 FY2024 | Mar 31, 2024 | 99.6% | +9.6 |
| Q4 FY2023 | Dec 31, 2023 | 99.7% | +26.8 |
| Q3 FY2023 | Sep 30, 2023 | 98.8% | +0.1 |
| Q2 FY2023 | Jun 30, 2023 | 99.0% | +8.7 |
| Q1 FY2023 | Mar 31, 2023 | 90.0% | −7.9 |
| Q4 FY2022 | Dec 31, 2022 | 72.9% | −22.8 |
| Q3 FY2022 | Sep 30, 2022 | 98.6% | −1.0 |
| Q2 FY2022 | Jun 30, 2022 | 90.3% | −3.5 |
| Q1 FY2022 | Mar 31, 2022 | 97.9% | +7.3 |
| Q4 FY2021 | Dec 31, 2021 | 95.7% | −1.8 |
| Q3 FY2021 | Sep 30, 2021 | 99.7% | +5.8 |
| Q2 FY2021 | Jun 30, 2021 | 93.8% | −3.9 |
| Q1 FY2021 | Mar 31, 2021 | 90.6% | – |
| Q4 FY2020 | Dec 31, 2020 | 97.4% | – |
| Q3 FY2020 | Sep 30, 2020 | 93.9% | – |
| Q2 FY2020 | Jun 30, 2020 | 97.6% | – |
See a number that looks wrong?